Article | July 10, 2018

Age Diversity In Clinical Trials: Addressing The Unmet Need

Source: Rho

By Ryan Bailey

Age Diversity In Clinical Trials: Addressing The Unmet Need

In a recent New York Times article, Paula Span raises the concern that elderly subjects are frequently omitted from clinical trials.  Consequently, physicians know very little about how a given treatment may affect their older patients.  Is a medication effective for the elderly?  Is it safe?  Without data, how is a physician to know?  

Span’s article is timely and aligns well with similar industry trends toward increased patient centricity and trial diversity.  Yet, expanding trials to include older patients poses a challenge for research teams because it brings two tenets of quality research into conflict with one another – representative study populations and patient safety.